According to a study published in The BMJ, while e-cigarettes can assist smokers to quit, the number of days of e-cigarette use will determine quit attempt and quit success.
While e-cigarettes can assist smokers to quit, the number of days of e-cigarette use will determine quit attempt and quit success, according to a study published in The BMJ.
Researchers at the University of California, San Francisco, who conducted the study analyzed data from the US Current Population Survey-Tobacco Use Supplement (2001-2002, 2003, 2006-2007, 2010-2011, and 2014-2015), but e-cigarette use was obtained only from the total sample (n = 161,054) from the 2014-2015 survey. Smoking cessation rates were obtained from those who quit smoking cigarettes 12 months prior to the survey (n = 23,270) and compared with the quit rates from the 2010-2011 survey and 3 others.
The primary outcome measures were the rate of attempt to quit cigarette smoking and the rate of successful quitting (meaning having abstained from cigarette smoking for 3 months).
Of the 2014-2015 sample, 22,548 were current smokers and 2136 were recent quitters—38.2% of current smokers and 49.3% of recent quitters had tried e-cigarettes. Of this subpopulation, 11.5% and 19%, respectively, currently use e-cigarettes and were the more likely population to quit smoking: 65.1% vs 40.1%. they also stood a much greater chance of quit success (8.2% vs 4.8%).
The authors write that while only 1.4% of smokers were current users of e-cigarettes in 2010, the number rose to between 15% and 30% by 2014; this meant that comparing the quit rates for those 2 periods would provide the most accurate impact of e-cigarette use on quitting.
E-cigarettes appear to have helped to increase smoking cessation at the population level, the authors conclude based on their study results.
IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies
November 21st 2023A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.
Read More